ENTHEON BIOMEDICAL CORP. Financial comparisons Entheon Biomedical Corp.
Equities
ENBI
CA29383X2023
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1700 CAD | 0.00% |
|
+25.93% | +70.00% |
Main competitors
| Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 7.66B | +9.74% | +13.98% | +6.52% | +3.82% | 0.46x | ||
| 14.98B | +9.06% | +20.36% | +32.01% | +5.22% | 3.45x | ||
| 1.52B | +24.61% | +29.93% | +5.07% | +4.31% | 1.46x | ||
| 8.12B | +7.54% | +19.31% | +6.90% | +3.58% | 2x | ||
| 6.85B | -68.84% | -61.90% | -28.59% | -21.29% | 2.38x | ||
| 2.33B | +42.31% | +50.91% | +18.27% | +14.91% | -1.85x | ||
| 1.16B | +14.50% | +31.94% | +14.11% | +6.29% | 0.4x | ||
| 1.89B | +15.00% | +17.94% | +59.83% | +18.80% | -0.29x | ||
| 4.13B | +11.49% | +20.31% | +16.70% | +6.95% | 2.34x | ||
| 1.97B | +17.37% | +26.90% | +4.69% | +2.75% | 0.69x | ||
| 11.58M | -3,768.28% | -4,207.12% | -34.76% | -30.38% | 3.85x | ||
| 532M | -40.26% | - | - | - | - | ||
| 1.02B | +27.44% | +35.35% | +9.95% | +7.09% | -1.51x | ||
| 1.59B | +13.88% | +14.92% | +13.86% | +6.82% | 1.36x | ||
| 249M | -203.30% | -194.99% | -157.13% | - | 0.99x | ||
| 788M | -46.45% | -44.80% | -76.34% | -13.26% | 3.21x | ||
| 658M | +19.38% | +22.41% | +9.00% | - | -1.79x | ||
| 325M | +1.04% | +10.29% | +34.35% | +12.03% | -1.95x | ||
| Average | 3.1B | -217.43% | -246.72% | -3.86% | +1.84% | 0.89x | |
| Weighted average by Cap. | 5.38B | -116.83% | -125.76% | +5.24% | +2.67% | 1.22x |
- Stock Market
- Equities
- ENBI Stock
- Sector Entheon Biomedical Corp.
- Financial comparisons